Health Canada has expanded the indication for clopidogrel [Plavix; sanofi-aventis, Bristol-Myers Squibb] to include patients with all acute coronary syndromes

Source: Inpharma, Volume 1, Number 1592, 2007-06-16 , pp. 23-23(1)

Publisher: Adis International

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

Keywords: Acute-coronary-syndromes, treatment; Aspirin, therapeutic use; Clopidogrel, therapeutic use; Development-status; Product-approvals

Document Type: Short communication

The full text electronic article is available for purchase. You will be able to download the full text electronic article after payment.

$37.95 plus tax

 

OR

Back to top

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A